PvP Biologics

Takeda Acquires Celiac-Focused PvP Biologics in Deal Worth $330 Million
BioSpace
Wed, 02/26/20 - 10:34 am
Takeda
PvP Biologics
celiac disease
M&A
TAK-062
Roswell, Organovo & More: Xconomy Awards Innovation at the Intersection Finalists
Xconomy
Thu, 04/25/19 - 06:52 pm
Organovo
Molecular Assemblies
MedCrypt
PvP Biologics
Roswell Biotechnologies
innovation
Tiny startup hooks Takeda in celiac deal
BioPharma Dive
Sat, 01/7/17 - 12:12 pm
Takeda
celiac disease
PvP Biologics